In the meta-analysis, SGLT2 inhibitors significantly reduced major adverse cardiovascular events (MACE), hospitalization for heart failure (HF) plus CV death, and progression of CKD by 11%, 23% and 33%, respectively, compared to placebo
Single amino acid N-terminal modifications in Exendin-4 can bias GLP-1R agonism, and substituting histidine for phenylalanine in position 1, as in Ex4-Phe1, promotes a marked reduction in -arrestin 1 and 2 recruitment
Fat Metabolism (Ketosis): As Mounjaro suppresses appetite and slows gastric emptying, your caloric intake drops
Screening of vitamin B12 in children diagnosed as Autism Spectrum Disorder: 3
It is licensed in the United States (under the brand name Egrifta) for HIV-associated lipodystrophy but has not been approved by the MHRA for any indication